The rejection of what would have been the first oral treatment for Type 1 diabetes in the U.S. is a big setback for Lexicon Pharmaceuticals Inc.
, a small company based in a Houston suburb that currently has one product on the market and losses of nearly $1.5 billion as of Dec. 31. Lexicon is developing the treatment, which is called Zynquista, with French pharmaceutical giant Sanofi.
Follow the $$.
Pending House Legislation requiring Medicare to negotiate drug prices requires HHS to favor domestic manufacturers over foreign ones, If they don't already have them, foreign companies would be forced to build/buy manufacturing facilities here.
Buena decisión.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA approves first treatment for postpartum depressionThe FDA has approved a new medication called Zulresso, a completely new class of drug designed specifically to treat postpartum depression. It’s a one-time infusion given in a hospital over two and a half days. Wow your born and time soviebe bebies Oh. I don't think I'd want to be breastfeeding with that in my system. Hey anything to keep women from killing there kids. It’s apparently a mental disorder.
Source: NBCNews - 🏆 10. / 86 Read more »
Sage Therapeutics’ Drug for Postpartum Depression Gets FDA NodU.S. health regulators on Tuesday approved Sage Therapeutics Inc.’s Zulresso, the first medication specifically intended for women with postpartum depression. Really? We need yet another drug to make a fortune for Pharma & who knows what side effects? Yes, I know PPD is serious & it’s likely _some_ ppl need meds. Shd be a more holistic solution: therapy, help home, 24/7 access to a known midwife, not just throw meds the problem Side effects?
Source: WSJ - 🏆 98. / 63 Read more »